MILabs

Heidelberglaan 100 STR 4.105
Utrecht
NL 3584 CX

Tel: 31-88-756-5343
Fax: 31-88-756-0094

Email: info@milabs.com

Show jobs for this employer

About MILabs

MILabs B.V. (Utrecht, the Netherlands) provides high-end molecular imaging solutions for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. As documented in over hundreds of scientific articles, U-SPECT provides the fastest, most sensitive and highest resolution small-animal SPECT system currently available. Recently MILabs fused state-of-the-art Adaptive PET with its SPECT technology by introducing VECTor/CT. This versatile nuclear imaging system is an extremely powerful non-invasive imaging system for small animals since it enables simultaneous sub-mm resolution PET/SPECT acquisitions of co-injected PET and SPECT tracers. Moreover, the VECTor platform offers the extreme flexibility of accommodating additional high-resolution, low-dose X-ray CT and Hybrid Optical luminescence and fluorescence imaging capabilities. For more information, visit www.milabs.com.
YEAR FOUNDED:
2006
LEADERSHIP:
Founder and CEO: Frederik Beekman
JOBS:
Please click here for MILabs job opportunities.
FOLLOW MILABS:

15 articles about MILabs